Posted on 10/12/17
Johnson & Johnson: The Need To Increase Margins, Growth
Johnson & Johnson's (JNJ) pharmaceutical segment is currently firing on all cylinders, but the same cannot be said about its consumer segment. In 2015, the segment . . .
Posted on 10/3/17
Pfizer: A Good Buy
I find Pfizer (PFE) a truly wonderful business. The reason for this is because the company is able to present its investors year after year with . . .
Posted on 9/26/17
Johnson & Johnson Is Not A Good Buy
By applying different what-if scenarios to Johnson & Johnson (JNJ), I arrived at a conclusion that a fair value would be more likely in the 70$ . . .
Posted on 9/12/17
Johnson & Johnson: How To Decrease Your Investment Returns
Writing options for great companies such as Johnson & Johnson (JNJ) is a sure way to decrease your returns. Option writing seems to be a fashionable . . .
Posted on 9/4/17
Johnson & Johnson: How Does An $11 Special Dividend Sound To You?
The price Johnson & Johnson (JNJ) paid for acquiring Actelion has most likely been a bit too high and destroyed shareholder wealth.Even through the acquisition of . . .
Posted on 8/8/17
Waters Is Minting Money
I find Waters (WAT) a truly wonderful business. The reason for this is because the company is able to present its investors year after year with . . .

